MAPT and Insulin resistance: p-tau may cause mitochondrial damage, such as insulin resistance or lack of insulin, mitophagy impairment, axonal transport disruption, mitochondrial bioenergetics, mitochondrial dynamics, Abeta toxicity, and inflammation involved in DRN (for more information on the mechanism diagram, please refer to Figure 2).